Chronic low-dose intravenous immunoglobulins as steroid-sparing therapy in myasthenia gravis. Wilf-Yarkoni A, Lotan I, Steiner I, Hellmann MA, et al. J Neurol 2021 Apr 7. pii: 10.1007/s00415-021-10544.

Read + Share

Amedeo Smart

Independent Medical Education

Wilf-Yarkoni A, Lotan I, Steiner I, Hellmann MA, et al. Chronic low-dose intravenous immunoglobulins as steroid-sparing therapy in myasthenia gravis. J Neurol 2021 Apr 7. pii: 10.1007/s00415-021-10544.
PMID: 33829320